Clinical Trial: A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: COPD (Chronic Obstructive Pulmonary Disease)
Study Type: INTERVENTIONAL
Official Title: A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects
Brief Summary:
To evaluate the safety and efficacy of Taneasy 600mg granules and Fluimucil 600mg granules administered twice daily for 14 days in treatment of COPD Disease.
Read more